Cohen Neil Harris Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
4
Insider Buys Sum
$129,637.59
Insider Sells Quantity
1
Insider Sells Sum
$4,818.00

Insider Activity of Cohen Neil Harris

According to the SEC Form 4 filings, Cohen Neil Harris, being in a position of

  1. director at Chemomab Therapeutics Ltd.,
    оver the last 12 months, has bought 0 shares, and sold 2304 shares for $6,516,
    over all time since 2021-03-16, has bought 8409 shares for $129,638, and sold 4713 shares for $11,334.

Biography of Cohen Neil Harris

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $6,5162100

Comparison of Insiders on Amount of Buys and Sells

2026-08-28SaleChemomab Therapeutics Ltd.
CMMB
director
1,000
0.0129%
$2.80$2,800-48.16%
2026-08-27SaleChemomab Therapeutics Ltd.
CMMB
director
1,304
0.0171%
$2.85$3,716-48.16%
2022-11-16SaleChemomab Therapeutics Ltd.
CMMB
director
2,409
0.0186%
$2.00$4,818-32.46%
2022-05-18PurchaseChemomab Therapeutics Ltd.
CMMB
2,000
0.0183%
$3.19$6,380-26.14%
2022-03-14PurchaseChemomab Therapeutics Ltd.
CMMB
2,000
0.0186%
$4.20$8,400-27.2%
2021-12-06PurchaseChemomab Therapeutics Ltd.
CMMB
director
2,000
0.0175%
$7.43$14,860-54.24%
2021-03-16PurchaseChemomab Therapeutics Ltd.
CMMB
director
2,409
0.0169%
$41.51$99,998-83.55%
Total: 7
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.